Dr Alan Watts is Director of Innovation & Partnerships for Orally Inhaled Products at Catalent. He has nearly 15 years’ experience in the development of inhalation products in both industrial and academic settings. Prior to Catalent, Dr Watts was Associate Director of Pharmaceutical Development for Savara Pharmaceuticals, leading combination product development, and Research Assistant Professor at the University of Texas at Austin, where he oversaw an aerosol research lab, taught Pharmacy courses and co-invented a novel dry powder inhalation platform. Dr Watts has a PhD in Pharmaceutics from the University of Texas at Austin and a BS in Biomedical Engineering from Louisiana Tech University.